EVENTBRITE INC-CLASS A (EB)

US29975E1091 - Common Stock

3.67  +0.08 (+2.23%)

After market: 3.67 0 (0%)

Fundamental Rating

2

Overall EB gets a fundamental rating of 2 out of 10. We evaluated EB against 72 industry peers in the Entertainment industry. EB has a bad profitability rating. Also its financial health evaluation is rather negative. EB is quite expensive at the moment. It does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year EB has reported negative net income.
EB had a positive operating cash flow in the past year.
EB had negative earnings in each of the past 5 years.
EB had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

EB's Return On Assets of -0.99% is in line compared to the rest of the industry. EB outperforms 57.58% of its industry peers.
The Return On Equity of EB (-4.52%) is better than 60.61% of its industry peers.
Industry RankSector Rank
ROA -0.99%
ROE -4.52%
ROIC N/A
ROA(3y)-8.16%
ROA(5y)-12.25%
ROE(3y)-42.98%
ROE(5y)-43.26%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 70.22%, EB belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
EB's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for EB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.72%
GM growth 5Y3.3%

2

2. Health

2.1 Basic Checks

EB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EB has more shares outstanding
EB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EB has been reduced compared to a year ago.

2.2 Solvency

EB has an Altman-Z score of -0.44. This is a bad value and indicates that EB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.44, EB is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
EB has a Debt/Equity ratio of 1.34. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.34, EB is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF N/A
Altman-Z -0.44
ROIC/WACCN/A
WACC5.61%

2.3 Liquidity

EB has a Current Ratio of 1.56. This is a normal value and indicates that EB is financially healthy and should not expect problems in meeting its short term obligations.
EB has a Current ratio of 1.56. This is in the better half of the industry: EB outperforms 63.64% of its industry peers.
EB has a Quick Ratio of 1.56. This is a normal value and indicates that EB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of EB (1.56) is better than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.09% over the past year.
EB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.54%.
Measured over the past years, EB shows a small growth in Revenue. The Revenue has been growing by 2.26% on average per year.
EPS 1Y (TTM)59.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)8.54%
Revenue growth 3Y45.44%
Revenue growth 5Y2.26%
Sales Q2Q%-4.59%

3.2 Future

Based on estimates for the next years, EB will show a very strong growth in Earnings Per Share. The EPS will grow by 25.44% on average per year.
EB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.83% yearly.
EPS Next Y52.09%
EPS Next 2Y41.91%
EPS Next 3Y28.86%
EPS Next 5Y25.44%
Revenue Next Year-0.63%
Revenue Next 2Y1.98%
Revenue Next 3Y6.41%
Revenue Next 5Y6.83%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

EB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
EB is valuated quite expensively with a Price/Forward Earnings ratio of 989.75.
EB's Price/Forward Earnings ratio is in line with the industry average.
EB is valuated expensively when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 989.75

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EB does not grow enough to justify the current Price/Earnings ratio.
EB's earnings are expected to grow with 28.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.91%
EPS Next 3Y28.86%

0

5. Dividend

5.1 Amount

EB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EVENTBRITE INC-CLASS A

NYSE:EB (1/3/2025, 8:04:00 PM)

After market: 3.67 0 (0%)

3.67

+0.08 (+2.23%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners93.3%
Inst Owner Change-8.2%
Ins Owners3.42%
Ins Owner Change23.44%
Market Cap355.55M
Analysts77.14
Price Target5.16 (40.6%)
Short Float %5.69%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)94.06%
Min EPS beat(2)69.74%
Max EPS beat(2)118.39%
EPS beat(4)3
Avg EPS beat(4)58.38%
Min EPS beat(4)-34.1%
Max EPS beat(4)118.39%
EPS beat(8)7
Avg EPS beat(8)57.9%
EPS beat(12)8
Avg EPS beat(12)30.44%
EPS beat(16)11
Avg EPS beat(16)26.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.7%
Min Revenue beat(2)-5.02%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-2.77%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)-0.39%
Revenue beat(8)1
Avg Revenue beat(8)-2.12%
Revenue beat(12)3
Avg Revenue beat(12)-0.58%
Revenue beat(16)5
Avg Revenue beat(16)0.6%
PT rev (1m)-1.22%
PT rev (3m)-1.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3542.86%
EPS NY rev (1m)31.66%
EPS NY rev (3m)43.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-23.01%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 989.75
P/S 1.06
P/FCF N/A
P/OCF 124.93
P/B 1.98
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)0
Fwd EY0.1%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.03
OCFY0.8%
SpS3.47
BVpS1.86
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.99%
ROE -4.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.22%
FCFM N/A
ROA(3y)-8.16%
ROA(5y)-12.25%
ROE(3y)-42.98%
ROE(5y)-43.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.72%
GM growth 5Y3.3%
F-Score7
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.27%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z -0.44
F-Score7
WACC5.61%
ROIC/WACCN/A
Cap/Depr(3y)31.86%
Cap/Depr(5y)35.85%
Cap/Sales(3y)1.75%
Cap/Sales(5y)3.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y52.09%
EPS Next 2Y41.91%
EPS Next 3Y28.86%
EPS Next 5Y25.44%
Revenue 1Y (TTM)8.54%
Revenue growth 3Y45.44%
Revenue growth 5Y2.26%
Sales Q2Q%-4.59%
Revenue Next Year-0.63%
Revenue Next 2Y1.98%
Revenue Next 3Y6.41%
Revenue Next 5Y6.83%
EBIT growth 1Y32.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year189.46%
EBIT Next 3Y52.18%
EBIT Next 5Y29.52%
FCF growth 1Y-123.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.64%
OCF growth 3YN/A
OCF growth 5Y21.58%